PH 45

Drug Profile

PH 45

Latest Information Update: 17 Jan 2011

Price : $50

At a glance

  • Originator Pherin Pharmaceuticals
  • Class
  • Mechanism of Action Testosterone antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Benign prostatic hyperplasia

Most Recent Events

  • 17 Jan 2011 Preclinical development is ongoing in USA
  • 17 Jan 2011 PH 45 is available for licensing as of 17 Jan 2011.
  • 15 Nov 2000 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top